DK0821960T3 - Anvendelse af xanthinderivater i kombination med et 5-isoxazol-4-carboxylsyreamidderivat og/eller et 2-cyano-3-hydroxy-crotonsyre-amidderivat til modulering af apoptose - Google Patents

Anvendelse af xanthinderivater i kombination med et 5-isoxazol-4-carboxylsyreamidderivat og/eller et 2-cyano-3-hydroxy-crotonsyre-amidderivat til modulering af apoptose

Info

Publication number: DK0821960T3
Authority: DK; Denmark
Prior art keywords: acid amide; amide derivative; alkyl; isoxazole; cyano
Prior art date: 1996-07-31

Application number

DK97112939T

Other languages

English (en)

Inventor

Stefan Dr Muellner

Claudia Dch Dax

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-31

Filing date

1997-07-28

Publication date

2003-07-21

1996-10-01 Priority claimed from DE19640556A external-priority patent/DE19640556A1/de

1997-07-28 Application filed by Hoechst Ag filed Critical Hoechst Ag

2003-07-21 Application granted granted Critical

2003-07-21 Publication of DK0821960T3 publication Critical patent/DK0821960T3/da

Links

230000006907 apoptotic process Effects 0.000 title abstract 3
RABDQLJWMPZANR-ARJAWSKDSA-N (z)-2-cyano-3-hydroxybut-2-enamide Chemical class C\C(O)=C(/C#N)C(N)=O RABDQLJWMPZANR-ARJAWSKDSA-N 0.000 title 1
LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 title 1
229940083747 low-ceiling diuretics xanthine derivative Drugs 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 7
125000001475 halogen functional group Chemical group 0.000 abstract 3
150000001875 compounds Chemical class 0.000 abstract 2
125000000753 cycloalkyl group Chemical group 0.000 abstract 2
125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 2
JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Immunology (AREA)
Neurology (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Oncology (AREA)
Biomedical Technology (AREA)
Virology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Tropical Medicine & Parasitology (AREA)
Communicable Diseases (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Steroid Compounds (AREA)

DK97112939T 1996-07-31 1997-07-28 Anvendelse af xanthinderivater i kombination med et 5-isoxazol-4-carboxylsyreamidderivat og/eller et 2-cyano-3-hydroxy-crotonsyre-amidderivat til modulering af apoptose DK0821960T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19630837		1996-07-31
DE19640556A DE19640556A1 (de)	1996-10-01	1996-10-01	Verwendung von Xanthinderivaten zur Modulation der Apoptose

Publications (1)

Publication Number	Publication Date
DK0821960T3 true DK0821960T3 (da)	2003-07-21

Family

ID=26027961

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97112939T DK0821960T3 (da)	1996-07-31	1997-07-28	Anvendelse af xanthinderivater i kombination med et 5-isoxazol-4-carboxylsyreamidderivat og/eller et 2-cyano-3-hydroxy-crotonsyre-amidderivat til modulering af apoptose

Country Status (11)

Country	Link
US (1)	US5856330A (da)
EP (1)	EP0821960B1 (da)
JP (1)	JPH1067662A (da)
AT (1)	ATE236637T1 (da)
AU (1)	AU718237B2 (da)
CA (1)	CA2212205C (da)
DE (1)	DE59709755D1 (da)
DK (1)	DK0821960T3 (da)
ES (1)	ES2191794T3 (da)
MX (1)	MX9705771A (da)
PT (1)	PT821960E (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6011051A (en) *	1996-07-31	2000-01-04	Hoechst Aktiengesellschaft	Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
DE19860802A1 (de) *	1998-12-30	2000-10-26	Virgene Pharmaceuticals Ag	Herstellung eines Mittels gegen Hepatitis B-, HI-, Paramyxo und Orthomyxo-Viren
US6458930B1 (en)	2000-11-28	2002-10-01	Cytokinetics, Inc.	Aspergillus fumigatus cofilin
GB0123571D0 (en)	2001-04-05	2001-11-21	Aventis Pharm Prod Inc	Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
FR2825928B1 (fr) *	2001-06-18	2004-04-02	Ecole Norm Superieure Cachan	Composition pharmaceutique pour le diagnostic, la prevention ou le traitement d'une pathologie tumorale, comprenant un agent modulateur de l'etat polymerisation de l'actine
CN1329078C (zh)	2001-12-28	2007-08-01	阿斯比奥制药株式会社	造血干细胞和/或造血前体细胞的增殖和/或分化促进剂
DE10217254A1 (de) *	2002-04-15	2003-10-23	Proteosys Ag	Verwendung von Substanzen zur Behandlung von Tumoren
GB0224014D0 (en) *	2002-10-15	2002-11-27	Oxford Glycosciences Uk Ltd	A protein involved in therapy

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3737433A (en) *	1964-09-05	1973-06-05	Albert Ag Chem Werke	Certain oxoalkyldimethylxanthines
DE2335170C2 (de) *	1973-07-11	1989-07-20	Hoechst Ag, 6230 Frankfurt	1,3-Dialkyl-7-(hydroxyalkyl)-xanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
NL186239B (nl) *	1975-06-05		Hoechst Ag	Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE3508097A1 (de) *	1984-07-21	1986-02-06	Hoechst Ag, 6230 Frankfurt	Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
DE3525801A1 (de) *	1985-07-19	1987-01-22	Hoechst Ag	Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
IL106859A (en) *	1986-12-31	1996-10-16	Hoechst Roussel Pharma	Pentoxifilin metabolites and pharmaceutical preparations containing them for the treatment of VIH and similar diseases
IL99811A (en) *	1990-10-30	1996-03-31	Roussel Uclaf	3-cycloalkyl-propanamides their tautomer forms and their salts preparation process and compositions containing them
AU9084991A (en) *	1990-11-01	1992-05-26	Board Of Regents, The University Of Texas System	Antifungal activity of and prevention of drug induced nephrotoxicity by methylxanthine analogues
DE59207086D1 (de) *	1991-05-23	1996-10-17	Hoechst Ag	Die Verwendung von 1-(5-Oxohexyl)-3-methyl-7-n-propyl-xanthin in der Gefässchirurgie
JP3566719B2 (ja) *	1991-05-24	2004-09-15	フレッドハッチンソンキャンサーリサーチセンター	外来性刺激に対する細胞性応答の調整
MX9203323A (es) *	1991-07-11	1994-07-29	Hoechst Ag	El empleo de derivados de xantina para el tratamiento de lesiones secundarias de las celulas nerviosas y trastornos funcionales despues de traumas craneo-cerebrales.
TW209834B (da) *	1991-12-11	1993-07-21	Hoechst Ag
GB9200275D0 (en) *	1992-01-08	1992-02-26	Roussel Lab Ltd	Chemical compounds
DK0557876T3 (da) *	1992-02-22	1997-05-26	Hoechst Ag	Anvendelse af xanthinderivater til behandling af muskelskader efter fuldstændig afbrydelse af blodcirkulationen
US5763446A (en) *	1992-03-26	1998-06-09	University Of Southern California	Use of pentoxifylline and other tumor necrosis factor blockers for the treatment of aids-associated optic neuropathy and other central nervous system diseases
GB9321083D0 (en) *	1993-10-13	1993-12-01	Univ Mcgill	Phosphatase inhibitors in channel diseases
US5519042A (en) *	1994-01-13	1996-05-21	Hoechst Aktiengesellschaft	Method of treating hyperproliferative vascular disease
AU3539795A (en) *	1994-08-25	1996-03-14	Medical University Of South Carolina	Methods of treating cold symptoms using pentoxifylline
CA2208580A1 (en) *	1994-12-29	1996-07-11	The Regents Of The University Of California	Compounds for inhibition of ceramide-mediated signal transduction

1997
- 1997-07-23 US US08/899,023 patent/US5856330A/en not_active Expired - Lifetime
- 1997-07-28 DE DE59709755T patent/DE59709755D1/de not_active Expired - Fee Related
- 1997-07-28 PT PT97112939T patent/PT821960E/pt unknown
- 1997-07-28 ES ES97112939T patent/ES2191794T3/es not_active Expired - Lifetime
- 1997-07-28 DK DK97112939T patent/DK0821960T3/da active
- 1997-07-28 AT AT97112939T patent/ATE236637T1/de not_active IP Right Cessation
- 1997-07-28 EP EP97112939A patent/EP0821960B1/de not_active Expired - Lifetime
- 1997-07-29 AU AU32367/97A patent/AU718237B2/en not_active Ceased
- 1997-07-30 CA CA002212205A patent/CA2212205C/en not_active Expired - Fee Related
- 1997-07-30 JP JP9204345A patent/JPH1067662A/ja not_active Ceased
- 1997-07-30 MX MX9705771D patent/MX9705771A/es not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2212205C (en)	2007-12-04
ES2191794T3 (es)	2003-09-16
US5856330A (en)	1999-01-05
DE59709755D1 (de)	2003-05-15
EP0821960A1 (de)	1998-02-04
CA2212205A1 (en)	1998-01-31
EP0821960B1 (de)	2003-04-09
ATE236637T1 (de)	2003-04-15
AU3236797A (en)	1998-02-05
PT821960E (pt)	2003-08-29
JPH1067662A (ja)	1998-03-10
AU718237B2 (en)	2000-04-13
MX9705771A (es)	1998-08-30

Publication	Publication Date	Title
DE59611022D1 (de)	2004-07-15	Zubereitung, enthaltend Lipoproteine und Crotonsäureamidderivate
EG19884A (en)	1996-10-31	Morpholinourea derivatives
DE59709755D1 (de)	2003-05-15	Verwendung von Xanthinderivaten in Kombination mit einem 5-Isoxazol-4-carbonsäureamid Derivat und/oder einem 2-Cyano-3-hydroxy-crotonsäureamid Derivat zur Modulation der Apoptose
ATE262901T1 (de)	2004-04-15	Verwendung von isoxazol- und crotonsäureamidderivaten zur modulation der apoptose
DK0769296T3 (da)	2001-10-22	Anvendelse af et natrium- eller lysiniumsalt af crotonsyreamidderivater til fremstilling af et lægemiddel til behandling af cancer
EA200000679A1 (ru)	2000-12-25	Фунгицидная смесь на базе амидных соединений и производных морфолина, соответственно, пиперидина
FI962768A0 (fi)	1996-07-05	N-(2-ftaali-imidoetyyli)substituoituja transpiperidiini-2,5-dikarboksylaatteja
DK0829470T3 (da)	2000-05-22	2-Cyano-3,5-dihydroxy-hex-2-en-carboxylsyreamidderivater, fremgangsmåde til deres fremstilling og deres anvendelse som læge
ES478516A1 (es)	1979-07-16	Procedimiento para la preparacion de alfa-halometil amino acidos.
DK439384A (da)	1985-03-16	Derivater af 4-(3-alkynyloxy-2-hydroxypropyl)-piperazin-1-yl-n-phenylacetamid, fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende disse
ATE115578T1 (de)	1994-12-15	2-(3-oxypyridinyl)-1,3-dioxolan- und dioxanderivate, diese enthaltende mischungen und ein verfahren zur bekämpfung von pilzen unter verwendung dieser verbindungen.
NZ330169A (en)	1998-10-28	7-alkylamino-6,7,8,9-tetrahydro-cyclopenta[a]naphthalene derivatives
JPS57114593A (en)	1982-07-16	3-vinylcephalosporin derivative and manufacture
HU9401512D0 (en)	1994-08-29	2-amino-pyrazine-5-carboxamide derivatives process for producing them and their therapeutic application
GR77953B (da)	1984-09-25
DK0673934T3 (da)	2001-07-30	Aminoalkylbenzothiazolinoner, fremgangsmåde til fremstilling af sådanne forbindelser og farmaceutiske sammensætninger indeholdende disse